Regimen simplification and medication adherence: Fixed-dose versus loose-dose combination therapy for type 2 diabetes.

por Anna-Katharina Böhm, Udo Schneider, Jens Aberle, Tom Stargardt
Publicado 2021

Dapagliflozin effects on haematocrit, red blood cell count and reticulocytes in insulin-treated patients with type 2 diabetes

por Jens Aberle, Markus Menzen, Sebastian M. Schmid, Christoph Terkamp, Elmar Jaeckel, Katja Rohwedder, Markus F. Scheerer, John Xu, Weifeng Tang, Andreas L. Birkenfeld
Publicado 2020